ABPI response to clinical research vision

The government has published its vision for the future of clinical research, setting out how it intends to capitalise on the successes of the past year.

Today’s vision reflects the shared priorities we have for the future of clinical research. Richard Torbett

In response, Richard Torbett, Chief Executive of the Association of the British Pharmaceutical Industry:

“We’ve seen the power of clinical research in bringing us the vaccines that are now edging us closer to the end of this pandemic.

“Today’s vision reflects the shared priorities we have for the future of clinical research. This welcome framework sets out how we can work together to get clinical research up and running again and build an even stronger research environment in the UK.

“Our members are central to the success of UK science and we are committed to playing our part to embed the lessons from our response to COVID19 and to deliver on this ambition for NHS patients”.

TAGS
  • Clinical research

The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. 

Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner with organisations in the life sciences community and beyond to transform lives across the UK.